CDH1 and prostate adenocarcinoma: E-cadherin and β-catenin proteins are described as valuable tumor markers, as their altered expression has been shown to correlate with increased tumor aggressiveness and dedifferentiation in human cancers, including prostatic adenocarcinoma.